Imgatuzumab

Imgatuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Imgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer).

Trade Name Imgatuzumab
Generic Imgatuzumab
Imgatuzumab Other Names Imgatuzumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Imgatuzumab
Imgatuzumab

Innovators Monograph

You find simplified version here Imgatuzumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share